Your Money with Michelle Martin

How far can $1,350 a month really take you in retirement? Hosted by Michelle Martin, this episode explores CPF Life and whether the Standard or Escalating Plan is better suited for your golden years. Daniel Sim, Founder of Golden Goose Properties, joins the conversation to unpack the trade-offs of starting payouts at 65 versus delaying till 70. They also discuss strategies to supplement CPF with rental income, downsizing, or non-property investments. If your retirement target is $2,500–$4,500 a month, where will the extra cash flow come from? Tune in to learn how to think of property as a secondary “CPF Life” and what other income streams can bridge the retirement gap. * The Full retirement sum is $213 000 for 2025, it will be $228 000 in 2027. This amount is the standard to set aside by age 55 on your Retirment Account to receive monthly payouts under the CPF LIFE Standard Plan upon reaching the Payout Eligibility Age. 

What if your entire business trajectory could change with one client?  Meet author Tim Castle, one of the world’s Top 30 Negotiation Professionals and author of The First Domino. Tim walks us through his new playbook for anyone who wants their first big break and big client. What's the link between communication frameworks, confidence and magic in sales psychology as shared in this book?  Tim shares the mindset shifts, and emotional intelligence that let small players punch above their weight in big deals. Learn how to engineer trust quickly and make the choices that can help you land that first client in under 90 days in this conversation.

AI is the new oil—and Korea’s stock market just struck it big. Hosted by Michelle Martin solo, she unpacks the record-breaking rally in the KOSPI driven by Samsung and SK Hynix’s AI partnership with OpenAI. We dive into BYD’s first monthly sales decline of the year and what it signals for China’s EV wars. In our Up-or-Down round, we tackle USA Rare Earth’s jump on White House talks, Intel’s 50% surge in just one month, Buffett’s $10B buy of Occidental’s OxyChem, and why analysts are turning bullish on Singapore REITs. Companies discussed include BYD, Samsung, SK Hynix, Intel, Berkshire Hathaway, Occidental, USA Rare Earth, and S-REITs. Tune in for the key takeaways to carry into the weekend.

Are more in Singapore rewriting the rules of work and retirement? Hosted by Michelle Martin with guest Ashmita Acharya, Head of International Wealth and Premier Banking, HSBC Singapore, this episode explores how Singaporeans are trading the “work till 65” model for intentional career pauses. We unpack HSBC findings that show 40% of Singaporeans planning mini-retirements aim to keep costs under $100K - signaling a shift from privilege to mainstream. From burnout relief to pursuing passion projects, mini-retirements are reshaping financial and life planning. How are they being funded - CPF, dividends, disciplined savings? And what are the non-financial hurdles that trip people up? Discover practical tips for anyone inspired to design a career with breaks built in, without sacrificing long-term security.

Singapore takes the spotlight as IPOs surge and CICT overtakes Hong Kong’s Link Reit. Hosted by Michelle Martin with Ryan Huang, this episode unpacks the big shifts across Singapore’s markets. We look at CICT, Link Reit, LHN, DBS, UOB, OCBC, and Nintendo, and what these moves mean for investors. From dividend growth to co-living IPOs, and from stablecoins like XSGD to Buffett’s next big bet—what signals should you watch? Will Singapore cement its position as Asia’s IPO hub, or is this momentum fragile? And as US shutdown risks loom, how might markets price in uncertainty? 

What if happiness could be decoded for teens - and their parents? Hosted by Michelle Martin, this episode dives into Andrew Matthews’ Being a Happy Teen 2025, a complete rewrite of his classic bestseller read by millions worldwide. We explore why self-love tops the list, how to understand parents, and the secret of champions that builds resilience. Andrew reveals why happiness isn’t just a goal but a skill teens can learn. From handling bullies to dealing with disappointment, his practical wisdom shines through. A must-listen for anyone guiding or growing through the teenage years.  

Singapore’s IPO market is on fire - and it’s the strongest in over a decade! Hosted by Michelle Martin, this episode dives into the surge fueled by MAS’s S$5B liquidity fund, tax rebates, and record-breaking listings like Centurion Accommodation REIT and AvePoint’s dual debut. Malcolm Koo, CEO of CGS International Singapore, shares insights on sector shifts to AI, renewables, and healthcare. We explore investor sentiment trends across institutional and global funds. Plus, what reforms are still needed to keep the momentum going? And how should investors rethink portfolios to seize these new opportunities?

A $55B gaming takeover shakes Wall Street and Asia-Pacific markets! Hosted by Michelle Martin who breaks down Electronic Arts’ mega buyout, market reactions, and the companies moving the needle today. Featuring Tata Group, Etsy, CapitaLand C-REIT, Yangzijiang Shipbuilding, and SingTel, we track winners, losers, and where markets head next. Will a looming U.S. shutdown weigh on sentiment? And which stocks are set for an Up or Down call? Get the Last Word on what’s driving the STI and beyond—all in one fast-moving show!

Pharma stocks plunge as Trump’s 100% tariffs send shockwaves across Asia. Hosted by Michelle Martin, we break down the impact on Singapore’s $4 billion pharma exports, Sumitomo Pharma, CSL, and more. Are these tariffs a short-term blow or a long-term reset for Asian healthcare investments? Plus, we spotlight Mapletree’s three Singapore REITs - Logistics, Industrial, and Pan-Asia Commercial - amid expected rate cuts.  Which one offers the best dividend yield and growth potential? Dividend Titan’s Willie Keng shares his strategy for navigating healthcare risks and REIT opportunities.  

Palm oil scandal, pharma tariffs, market jitters - what’s next for global investors? Hosted by Michelle Martin with Ryan Huang, we unpack Wilmar International’s corruption fallout, Donald Trump’s 100% pharma tariffs, and Chugai Pharmaceutical and Novo Nordisk’s market reaction. We explore the Buffett Indicator’s warning on U.S. equities, Nike’s upcoming earnings, and local market movers like Centurion Accommodation REIT, CapitaLand India Trust, and Jardine Matheson. Plus, our daily UP or DOWN verdict on Lululemon, Microsoft, and more. A fast-moving episode on scandals, stocks, and strategy.